Skip to main navigation Skip to search Skip to main content

Response to letter: "medullary thyroid carcinoma in MEN2A: Ata moderate- or high-risk ret mutations do not predict disease aggressiveness"

Research output: Contribution to journal › Letter › peer-review

Original languageEnglish (US)
Pages (from-to)3559
Number of pages1
JournalJournal of Clinical Endocrinology and Metabolism
Volume102
Issue number9
DOIs
StatePublished - Sep 1 2017

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this